SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity

Abstract The ability to image adoptively transferred T cells in the body and to eliminate them to avoid toxicity will be vital for chimeric antigen receptor (CAR) T cell therapy, particularly against solid tumors with higher risk of off-tumor toxicity. Previously, we have demonstrated the utility of...

Full description

Bibliographic Details
Main Authors: Yago Alcaina, Yanping Yang, Yogindra Vedvyas, Jaclyn E. McCloskey, Moonsoo M. Jin
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25224-z
_version_ 1811190332737454080
author Yago Alcaina
Yanping Yang
Yogindra Vedvyas
Jaclyn E. McCloskey
Moonsoo M. Jin
author_facet Yago Alcaina
Yanping Yang
Yogindra Vedvyas
Jaclyn E. McCloskey
Moonsoo M. Jin
author_sort Yago Alcaina
collection DOAJ
description Abstract The ability to image adoptively transferred T cells in the body and to eliminate them to avoid toxicity will be vital for chimeric antigen receptor (CAR) T cell therapy, particularly against solid tumors with higher risk of off-tumor toxicity. Previously, we have demonstrated the utility of somatostatin receptor 2 (SSTR2) for CAR T cell imaging, illustrating the expansion and contraction of CAR T cells in tumor as well as off-tumor expansion. Using intercellular adhesion molecule 1 (ICAM-1)-specific CAR T cells that secrete interleukin (IL)-12 as a model, herein we examined the potential of SSTR2 as a safety switch when combined with the SSTR2-specific maytansine-octreotate conjugate PEN-221. Constitutive secretion of IL-12 led to continuous expansion of CAR T cells after rapid elimination of tumors, causing systemic toxicity in mice with intact MHC expression. Treatment with PEN-221 rapidly reduced the abundance of CAR T cells, decreasing the severity of xenogeneic graft-versus-host disease (GvHD), and prolonged survival. Our study supports the development of SSTR2 as a single genetic marker for CAR T cells that is readily applicable to humans both for anatomical detection of T cell distribution and an image-guided safety switch for rapid elimination of CAR T cells.
first_indexed 2024-04-11T14:48:28Z
format Article
id doaj.art-b4d931c057124558b1311f10901b0857
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T14:48:28Z
publishDate 2022-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-b4d931c057124558b1311f10901b08572022-12-22T04:17:33ZengNature PortfolioScientific Reports2045-23222022-12-0112111210.1038/s41598-022-25224-zSSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicityYago Alcaina0Yanping Yang1Yogindra Vedvyas2Jaclyn E. McCloskey3Moonsoo M. Jin4Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell MedicineMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell MedicineMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell MedicineMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell MedicineMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell MedicineAbstract The ability to image adoptively transferred T cells in the body and to eliminate them to avoid toxicity will be vital for chimeric antigen receptor (CAR) T cell therapy, particularly against solid tumors with higher risk of off-tumor toxicity. Previously, we have demonstrated the utility of somatostatin receptor 2 (SSTR2) for CAR T cell imaging, illustrating the expansion and contraction of CAR T cells in tumor as well as off-tumor expansion. Using intercellular adhesion molecule 1 (ICAM-1)-specific CAR T cells that secrete interleukin (IL)-12 as a model, herein we examined the potential of SSTR2 as a safety switch when combined with the SSTR2-specific maytansine-octreotate conjugate PEN-221. Constitutive secretion of IL-12 led to continuous expansion of CAR T cells after rapid elimination of tumors, causing systemic toxicity in mice with intact MHC expression. Treatment with PEN-221 rapidly reduced the abundance of CAR T cells, decreasing the severity of xenogeneic graft-versus-host disease (GvHD), and prolonged survival. Our study supports the development of SSTR2 as a single genetic marker for CAR T cells that is readily applicable to humans both for anatomical detection of T cell distribution and an image-guided safety switch for rapid elimination of CAR T cells.https://doi.org/10.1038/s41598-022-25224-z
spellingShingle Yago Alcaina
Yanping Yang
Yogindra Vedvyas
Jaclyn E. McCloskey
Moonsoo M. Jin
SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
Scientific Reports
title SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
title_full SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
title_fullStr SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
title_full_unstemmed SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
title_short SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
title_sort sstr2 as an anatomical imaging marker and a safety switch to monitor and manage car t cell toxicity
url https://doi.org/10.1038/s41598-022-25224-z
work_keys_str_mv AT yagoalcaina sstr2asananatomicalimagingmarkerandasafetyswitchtomonitorandmanagecartcelltoxicity
AT yanpingyang sstr2asananatomicalimagingmarkerandasafetyswitchtomonitorandmanagecartcelltoxicity
AT yogindravedvyas sstr2asananatomicalimagingmarkerandasafetyswitchtomonitorandmanagecartcelltoxicity
AT jaclynemccloskey sstr2asananatomicalimagingmarkerandasafetyswitchtomonitorandmanagecartcelltoxicity
AT moonsoomjin sstr2asananatomicalimagingmarkerandasafetyswitchtomonitorandmanagecartcelltoxicity